Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNQ2 | O43526 | 2/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4810192 | 1.00 | KCNQ2 (0.34) | KCNQ2EPHX2MEN1HPGDKMT2A | |
| SCHEMBL14856319 | 0.90 | TRPV1 (0.33) | KCNQ2EPHX2 | |
| SCHEMBL14856318 | 0.90 | TRPV1 (0.33) | KCNQ2EPHX2 | |
| SCHEMBL3602932 | 0.87 | KCNQ2 (0.37) | KCNQ2EPHX2MEN1HPGDKMT2A | |
| SCHEMBL3599201 | 0.85 | MEN1 (0.36) | KCNQ2MEN1HPGDKMT2A | |
| SCHEMBL3599208 | 0.85 | MEN1 (0.36) | KCNQ2MEN1HPGDKMT2A | |
| SCHEMBL3600195 | 0.83 | HPGD (0.40) | KCNQ2MEN1HPGDKMT2A | |
| SCHEMBL4810181 | 0.83 | HTT (0.38) | KCNQ2HPGD | |
| SCHEMBL3598208 | 0.80 | HPGD (0.34) | KCNQ2MEN1HPGDKMT2A | |
| SCHEMBL3603206 | 0.80 | KCNQ2 (0.43) | KCNQ2EPHX2MEN1HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7465815-B2 | Cannabinoid receptor modulator | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-12-16 | — | — | US | disclosed |
| US-20070099990-A1 | Cannabinoid receptor modulator | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099990-A1 | Cannabinoid receptor modulator | CNR1, CNR2, GPR18 | KCNQ2 630/4885EPHX2 1518/4885MEN1 3532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.